Merck pays $250M to license Moderna cancer vaccine...


biopharmadive.com | 2022-10-25 16:38 UTC

The drugmakers decision to grab rights to the shot deepens its ties with the COVID-19 vaccine developer and comes weeks before a key data release.

By kynast on 2022-10-25 16:38 UTC
  • Need an account?  
    or